Posts by: Ana de Barros, PhD

News

Tilray Canada has launched its newest product, Tilray 2:100, a formulation of therapeutic cannabis oil containing a high concentration of cannabidiol (CBD), which may help treat Canadian patients with conditions ... Read more

April 5, 2018April 5, 2018

Biscayne Licenses Rights of Antiepileptic Therapy Candidate to Chinese Biopharma

News

Biscayne Neurotherapeutics has licensed the Chinese rights to its investigative antiepileptic therapy BIS-001ER to Global Drug Development Centre (GDCC) China in Taiwan, China, Hong Kong, and Macau. Biscayne is developing ... Read more

March 20, 2018March 20, 2018

GW Pharmaceuticals Receives Notices of Allowance for 5 Epidiolex Patent Applications

News

GW Pharmaceuticals announced that it recently received allowance notices from the U.S. Patent and Trademark Office (USPTO) for five new patent applications for Epidiolex (cannabidiol). Three of these applications specifically focus ... Read more

Posts by: Ana de Barros, PhD

Ana de Barros, PhD

Tilray Launches New High-CBD Cannabis Oil for Seizure Treatment in Canada

Biscayne Licenses Rights of Antiepileptic Therapy Candidate to Chinese Biopharma

GW Pharmaceuticals Receives Notices of Allowance for 5 Epidiolex Patent Applications

Pin It on Pinterest